Transcatheter Edge to Edge Repair (TEER) or MitraClip™

Community Heart and Vascular Hospital offers transcatheter edge to edge repair (TEER) with MitraClip™, an FDA-approved procedure appropriate for patients with mitral regurgitation (leaky mitral valve) who remain symptomatic despite medical treatment.

TEER is a minimally invasive procedure that involves inserting a catheter through a blood vessel up to the heart. The MitraClip device is inserted through the catheter and clips the valve flaps together to improve valve closure and decrease valve leaking. The mitral valve is repaired without open heart surgery.

Find a TEER Physician

Benefits of TEER or MitraClip

  • Minimally invasive procedure allows the mitral valve to be repaired without open heart surgery
  • Reduced healing time
  • Less time in the hospital
  • Restores quality of life
  • Excellent success rates
  • Patients are evaluated within our multidisciplinary valve clinic and images are reviewed by imaging specialists  
  • Patient-centered approach to care
  • Dedicated perioperative structural heart sonographers 
  • Close collaboration with advanced heart failure and electrophysiologist specialists  
  • More than 70 MitraClip procedures completed
  • First to use Enhanced Recovery After Surgery approach to facilitate recovery
  • Pre-operative nutrition screening and nutrition referrals to optimize recovery

What Is Mitral Valve Regurgitation?

Mitral valve regurgitation occurs when the heart’s mitral valve does not close completely. The incomplete closure results in blood flowing backwards across the valve. This can lead to fatigue, irregular heartbeats, shortness of breath, or swelling in the feet or legs as well as abdomen. Mitral valve regurgitation may also lead to heart failure or other more serious complications if left untreated.

When mitral regurgitation progresses to moderate-severe or severe and symptomatic stages, surgery is usually needed to replace or repair the valve. Mitral regurgitation can be structural (primary abnormality in valve itself) or functional (secondary usually due to dilatation of the main pumping chamber of the heart leading to stretching of the valve and leakage).

The FDA has approved the use of MitraClip in both structural and functional mitral regurgitation.

Questions and Appointments

If you have questions about the TEER or MitraClip procedure and if it may be right for your condition, please call Community’s structural heart team at 317-341-0176, or call 800-777-7775 for an appointment.